Asthma: Expanding the Medicine Chest
2006
New Treatment for Severe Asthma
Sample size: 17
publication
Evidence: moderate
Author Information
Author(s): Szpir Michael
Primary Institution: Southampton General Hospital
Hypothesis
If severe asthma is a Th1 disease, it would respond to a TNF-α blocker.
Conclusion
The treatment with etanercept showed significant improvements in asthma symptoms and lung function for patients with severe asthma.
Supporting Evidence
- Severe asthma was associated with neutrophils rather than eosinophils.
- Etanercept treatment led to significant improvements in asthma symptoms and lung function.
- Previous studies showed no improvement in mild asthma with etanercept.
Takeaway
A new medicine called etanercept might help people with really bad asthma feel better by blocking a certain part of their immune system.
Methodology
The study involved administering etanercept to 17 subjects with severe asthma over 12 weeks.
Limitations
Placebo-controlled studies are needed to fully assess the efficacy of anti-TNF-α therapy.
Participant Demographics
Participants were subjects with severe asthma.
Want to read the original?
Access the complete publication on the publisher's website